Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Canadian marketing clearance granted for Emdogain

Aug. 28, 1997

Pacific Pharmaceuticals and Steri-Oss sign distribution agreement

Aug. 28, 1997

Delmopinol inhibits gingivitis in extreme rates of plaque formation

Aug. 18, 1997

Marketing approval sought for Periostat in Italy

July 25, 1997

Lifecore Biomedical to distribute LifeCell's AlloDerm in U.S.

July 7, 1997

Emdogain approved in South Africa

July 3, 1997

State University of New York grants license to Noven for anticavity compounds

June 4, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Biora introduces Emdogain in the U.S.

April 21, 1997

Atrix submits NDA for Atridox

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...